Barclays Downgrades Chimerix (CMRX) to Equalweight

February 23, 2016 7:10 AM EST
Get Alerts CMRX Hot Sheet
Price: $6.35 +3.42%

Rating Summary:
    11 Buy, 7 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 7 | Down: 15 | New: 24
Trade Now! 
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

Barclays downgraded Chimerix (NASDAQ: CMRX) from Overweight to Equalweight with a price target of $6.00 (from $12.00).

For an analyst ratings summary and ratings history on Chimerix click here. For more ratings news on Chimerix click here.

Shares of Chimerix closed at $4.55 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst PT Change, Downgrades

Related Entities

Barclays